MEEDER ASSET MANAGEMENT INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
125
-6.0%
0.00%
Q2 2022$1,000
-50.0%
133
-69.0%
0.00%
Q1 2022$2,000
+100.0%
429
+793.8%
0.00%
Q3 2021$1,000
-85.7%
48
-87.9%
0.00%
Q2 2021$7,000
+600.0%
398
+552.5%
0.00%
Q1 2021$1,0000.0%610.0%0.00%
Q4 2020$1,0000.0%61
-11.6%
0.00%
Q3 2020$1,000
-80.0%
69
-65.0%
0.00%
Q2 2020$5,000
-58.3%
197
-70.2%
0.00%
-100.0%
Q1 2020$12,000
+71.4%
661
+117.4%
0.00%
Q4 2019$7,000
+40.0%
304
+20.2%
0.00%
Q3 2019$5,000
-99.4%
253
-98.9%
0.00%
-100.0%
Q2 2019$786,000
+2811.1%
22,084
+2667.4%
0.06%
+2650.0%
Q1 2019$27,000
+170.0%
798
+150.2%
0.00%
+100.0%
Q4 2018$10,000
-94.8%
319
-89.9%
0.00%
-93.3%
Q3 2018$194,000
-99.9%
3,163
-50.7%
0.02%
-44.4%
Q2 2018$313,489,000
+147077.9%
6,420
+220.0%
0.03%
+35.0%
Q1 2018$213,000
+76.0%
2,006
-0.4%
0.02%
+100.0%
Q4 2017$121,0002,0150.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders